Lactococcus Lactis R1058
Also known as: Lactococcus lactis, R1058, Lactococcus lactis R1058
Overview
*Lactococcus lactis* R1058 is a strain of gram-positive bacteria that is primarily found in fermented dairy products, particularly cheese and buttermilk. This strain belongs to the lactic acid bacteria (LAB) group and is widely employed in food fermentation for its lactic acid production abilities. While it is predominantly used in dairy processing, research indicates potential health benefits beyond its traditional applications, such as anti-inflammatory effects and probiotic properties. The strain is non-motile, non-sporulating, and homofermentative, contributing beneficially to gut health. Although studies exist on *L. lactis* strains, specific research focusing on R1058 is somewhat limited, indicating a moderate level of research maturity with variable evidence quality associated with its therapeutic potential.
Benefits
Research has indicated that *Lactococcus lactis* R1058 may exhibit anti-inflammatory and antioxidant properties. While specific benefits of this strain are not extensively documented, probiotics in general have been recognized for promoting gut health, enhancing immune function, and possibly reducing inflammation. These benefits can be especially useful for populations experiencing gut health issues. The effects observed in general *L. lactis* studies highlight the average anti-inflammatory response but lack quantifiable measures directly related to R1058. Overall, while R1058 shows promise, it requires further research to establish definitive benefits.
How it works
*Lactococcus lactis* R1058 functions primarily through modulating gut microbiota and producing anti-inflammatory compounds, such as interleukin-10 (IL-10). Its interaction with the gastrointestinal system helps maintain a balanced intestinal flora, which can influence various health parameters, including inflammation and immune response. Although specific molecular targets for R1058 are not identified, the bacterium contributes to local gut health without significant systemic absorption.
Side effects
The safety profile of *Lactococcus lactis* is generally considered to be favorable, with the strain being classified as Generally Recognized As Safe (GRAS). The common side effects associated with probiotic use may include mild gastrointestinal disturbances, such as bloating or gas. Uncommon side effects specific to R1058 are not documented. In rare cases, probiotics can lead to infections in immunocompromised individuals, necessitating caution for those with weakened immune systems. Pregnant women and individuals lacking stable immune function are advised to consult healthcare professionals before use.
Dosage
Recommended dosages for *Lactococcus lactis* R1058 have not been established, but probiotic dosing typically revolves around colony-forming units (CFUs). Common dosing ranges for probiotics generally recommend between 1 billion to 10 billion CFUs per day, depending on the objectives of use. Taking probiotics with meals may enhance their viability through the stomach. Specific dosages for R1058 are not defined, thus, consumers should follow product guidelines and consult healthcare providers for personalized dosage recommendations.
FAQs
How should I store *Lactococcus lactis* R1058?
Store in a cool, dry place to maintain viability.
Is it safe for everyone to take probiotics?
Generally safe, but individuals who are immunocompromised should consult a healthcare provider.
When is the best time to take *Lactococcus lactis* R1058?
It is best taken with meals to enhance survival rates through the digestive tract.
What results can I expect from taking this probiotic?
Results vary; users report potential improvements in gut health and immune function.
Are probiotics a guaranteed solution for gut issues?
No, probiotics are not a cure-all and may not benefit everyone equally.
Research Sources
- https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2024.1404652/full – This research examines the extracellular products of *Lactococcus lactis* and their role in reducing inflammatory factors and improving survival in experimental sepsis, indicating potential therapeutic applications.
- https://en.wikipedia.org/wiki/Lactococcus_lactis – This entry provides an overview of *Lactococcus lactis*, including its classification, applications in dairy fermentation, and general benefits demonstrated in various studies.
- https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2024.1418556/full – The article discusses various therapeutic applications of genetically engineered *Lactococcus lactis*, highlighting its potential to deliver proteins for conditions like inflammatory bowel disease.
- https://www.mdpi.com/2311-5637/10/1/16 – This source presents findings on the safety and effects of multi-strain probiotics, suggesting regulatory roles in the microbiota and addressing implications for general adult populations.
- https://www.researchgate.net/publication/340792332_Safety_and_Effect_of_a_Low-_and_High-Dose_Multi-Strain_Probiotic_Supplement_on_Microbiota_in_a_General_Adult_Population_A_Randomized_Double-Blind_Placebo-Controlled_Study – The study investigates the effects of multi-strain probiotics on microbiota in adults, emphasizing the importance of dosage and strain selection in achieving effects.
